AMANDA MAXWELL: Open Payments
NPI 1225352800 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 32 payments from 15 companies in 2025. Trend: 2023 $972 · 2024 $798 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $285 |
| Medtronic, Inc. | 1 | $165 |
| Viatris Specialty LLC | 3 | $93 |
| Merck Sharp & Dohme LLC | 3 | $90 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $44 |
| Stryker Corporation | 2 | $40 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $38 |
| Alexion Pharmaceuticals, Inc. | 1 | $32 |
| Smith+Nephew, Inc. | 1 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
Products named: DALVANCE, SYMPLICITY G3, YUPELRI, VERQUVO, JOURNAVX, FLOWTRIEVER, LifeVest, AVYCAZ.
Industry payments across FL — which companies pay providers there.
